Ignite Creation Date:
2025-12-24 @ 11:14 PM
Ignite Modification Date:
2026-05-28 @ 5:22 AM
Study NCT ID:
NCT01707069
Status:
COMPLETED
Last Update Posted:
2014-05-22
First Post:
2012-10-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Safety and Immunogenicity Phase I Study of CryJ2-DNA-Lysosomal Associated Membrane Protein (CryJ2 -DNA-LAMP) Plasmid
Sponsor:
Immunomic Therapeutics, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Allergic Rhinoconjunctivitis | View |
Keywords: